Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 2 |
2014 | 1 |
2019 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
ezzeddine cherif
(3 results)?
Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review.
Biomedicines. 2023 Mar 27;11(4):1024. doi: 10.3390/biomedicines11041024.
Biomedicines. 2023.
PMID: 37189646
Free PMC article.
Review.
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study.
Frey N, Jang JH, Szer J, Illés Á, Kim HJ, Ram R, Chong BH, Rowe JM, Borisenkova E, Liesveld J, Winer ES, Cherfi A, Aslanis V, Ghaznawi F, Strickland S.
Frey N, et al. Among authors: cherfi a.
Lancet Haematol. 2019 Mar;6(3):e122-e131. doi: 10.1016/S2352-3026(18)30231-X. Epub 2019 Jan 29.
Lancet Haematol. 2019.
PMID: 30704923
Clinical Trial.
Item in Clipboard
Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Yao JC, Pavel M, Phan AT, Kulke MH, Hoosen S, St Peter J, Cherfi A, Öberg KE.
Yao JC, et al. Among authors: cherfi a.
J Clin Endocrinol Metab. 2011 Dec;96(12):3741-9. doi: 10.1210/jc.2011-0666. Epub 2011 Oct 12.
J Clin Endocrinol Metab. 2011.
PMID: 21994954
Clinical Trial.
Item in Clipboard
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Wang M, Popplewell LL, Collins RH Jr, Winter JN, Goy A, Kaminski MS, Bartlett NL, Johnston PB, Lister J, Fanning SR, Tuscano JM, Beck JT, Kaya H, Robeva A, Fan J, Klimovsky J, Cheung W, Cherfi A, O'Connor OA.
Wang M, et al. Among authors: cherfi a.
Br J Haematol. 2014 May;165(4):510-8. doi: 10.1111/bjh.12780. Epub 2014 Mar 2.
Br J Haematol. 2014.
PMID: 24579926
Free article.
Clinical Trial.
Item in Clipboard
Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
Xu B, Wu Y, Shen L, Ye D, Jappe A, Cherfi A, Wang H, Yuan R.
Xu B, et al. Among authors: cherfi a.
J Hematol Oncol. 2011 Jan 13;4:3. doi: 10.1186/1756-8722-4-3.
J Hematol Oncol. 2011.
PMID: 21232120
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite